Refine by
-
NAMI Seeks Participants for Survey on Lived Experience of Borderline Personality Disorder
NAMI is conducting a Virtual Advisory Panel — an online platform for participants to anonymously answer a survey on how Borderline Personality Disorder (BPD) affects their life, work and relationships. -
Understanding the Symptoms of BPD
One of the best ways to create more understanding and empathy is to take a step back and try to understand the underlying causes of BPD symptoms. -
How I Manage the Side Effects of Antipsychotics
Antipsychotics can have negative side effects, but there are ways to compromise and keep them a valuable part of life. -
Healing from Heartbreak with BPD
"I understand that I feel things so much deeper than those who don’t live with BPD and that I should not act on each emotion." -
Making a Difference One Person at a Time
"Treating someone living with mental illness with dignity and kindness is one of the best things you can do for them." -
NAMI Hosting Free, Virtual Inspiring Hope Through Research Event
This year’s award honoree, Dr. David C. Henderson, is the Psychiatrist-in-Chief at Boston Medical Center and Professor and Chair of Psychiatry at Boston University School of Medicine. -
Why Stereotypes About Psychosis Are Harmful
"Maybe it’s not psychosis itself that’s perceived as scary, but rather the tightly held fear of the unknown." -
What I Want You to Know as Someone with BPD
"As someone living with BPD, and as a mental health professional, I can personally tell you how difficult it is to live with this disorder." -
The Importance of Accepting Help
Going through struggles in life is inevitable — but you can accept help to make it a little easier. -
NAMI Joins Public–Private Partnership to Advance Early Interventions for Schizophrenia
Today, NAMI announced it has joined the Accelerating Medicines Partnership (AMP) Schizophrenia (SCZ), which brings together NIH, the U.S. Food and Drug Administration and multiple non-profit and private organizations to work toward meeting the urgent need for early therapeutic interventions for people at risk of developing schizophrenia.
